{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:07:44Z","timestamp":1790194064198,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["PNRR-MR1-2022-12376811"],"award-info":[{"award-number":["PNRR-MR1-2022-12376811"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Current Research Funds"],"award-info":[{"award-number":["Current Research Funds"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Malan syndrome (MALNS), previously referred to as \u201cSotos syndrome 2\u201d due to its resemblance to Sotos syndrome (SS), is an ultra-rare neurodevelopmental disorder characterized by overgrowth, typical craniofacial features, intellectual disability (ID), and a range of psychobehavioral, musculoskeletal, vision and neurological signs. As MALNS and SS partly overlap, it is essential to more accurately profile their clinical presentations and highlight their differences in order to improve syndrome specific management. An increasing number of individuals with MALNS reach adult-age though the natural history of the disorder is poorly characterized due to the small number of adult individuals described so far. As a consequence, current guidelines are limited to the pediatric population. Further delineation of MALNS is essential to optimize care in adulthood.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A mixed approach based on cross-sectional data collection with a survey disseminated to caregivers of adults with molecularly confirmed MALNS and literature review was conducted. Twenty-eight caregivers completed the survey. Clinical presentation in adulthood is multisystemic and defined by psychobehavioral comorbidities (96%), musculoskeletal involvement (96%), vision impairment (96%) and neurological complications (86%). The most common signs were anxiety (79%), hypotonia (75%), movement difficulty (75%), scoliosis (64%), problems with coordination (61%), strabismus (57%), constipation (54%), breastbone abnormalities (54%) and advanced bone age during childhood (54%). Impaired vision was complicated by vision decline (36%) and optic atrophy (32%). We report some previously unidentified features, including high pain threshold (46%), incontinence (25%), tremors (21%), muscle hypoplasia (18%) and tics (18%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This survey in the adult population has allowed a more complete description of the natural history of MALNS. Our findings will contribute to the development and improvement of standards of care for adults with MALNS to assure optimal health monitoring and treatment of evolutive complications. We propose additional recommendations to the previous dataset of clinical evaluations specifically applied to adults. The comparison of MALNS and SS adult presentation highlights significant differences in terms of prevalence and severity of ID, behavioral issues, and vision problems, confirming that a proper differential diagnosis between the two conditions is indispensable to guide physicians and mental health professionals to syndrome specific management.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-024-03288-6","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T12:54:48Z","timestamp":1722257688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Natural history in Malan syndrome: survey of 28 adults and literature review"],"prefix":"10.1186","volume":"19","author":[{"given":"T. N.","family":"Huynh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. G.","family":"Delagrammatikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Chiriatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Panfili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ventarola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. A.","family":"Menke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Huisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4815-9550","authenticated-orcid":false,"given":"M.","family":"Priolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"key":"3288_CR1","doi-asserted-by":"crossref","unstructured":"Claussnitzer M, Cho JH, Collins R, Cox NJ, Dermitzakis ET, Hurles ME, et al. A brief history of human disease genetics. Nature. 2020;577(7789):179\u2013189.","DOI":"10.1038\/s41586-019-1879-7"},{"key":"3288_CR2","doi-asserted-by":"crossref","unstructured":"Parenti I, Rabaneda LG, Schoen H, Novarino G. Neurodevelopmental disorders: from genetics to functional pathways. Trends Neurosci 2020;43(8):608\u2013621.","DOI":"10.1016\/j.tins.2020.05.004"},{"issue":"1","key":"3288_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/ddrr.1130","volume":"18","author":"EM Dykens","year":"2013","unstructured":"Dykens EM. Aging in rare intellectual disability syndromes. Dev Disabil Res Rev. 2013;18(1):75\u201383.","journal-title":"Dev Disabil Res Rev"},{"key":"3288_CR4","unstructured":"Orphanet: Malan overgrowth syndrome. Available at: https:\/\/www.orpha.net\/consor\/cgi-bin\/OC_Exp.php?lng=EN&Expert=420179. Accessed Mar 29, 2023."},{"issue":"9","key":"3288_CR5","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/humu.23563","volume":"39","author":"M Priolo","year":"2018","unstructured":"Priolo M, Schanze D, Tatton-Brown K, Mulder PA, Tenorio J, Kooblall K, et al. Further delineation of Malan syndrome. Hum Mutat. 2018;39(9):1226\u201337.","journal-title":"Hum Mutat"},{"key":"3288_CR6","doi-asserted-by":"crossref","unstructured":"Malan V, Rajan D, Thomas S, Shaw AC, Louis Dit Picard H, Layet V, et al. Distinct effects of allelic NFIX mutations on nonsense-mediated mRNA decay engender either a Sotos-like or a Marshall-Smith syndrome. Am J Hum Genet 2010;87(2):189\u2013198.","DOI":"10.1016\/j.ajhg.2010.07.001"},{"issue":"1","key":"3288_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13023-022-02384-9","volume":"17","author":"M Macchiaiolo","year":"2022","unstructured":"Macchiaiolo M, Panfili FM, Vecchio D, Gonfiantini MV, Cortellessa F, Caciolo C, et al. A deep phenotyping experience: up to date in management and diagnosis of Malan syndrome in a single center surveillance report. Orphanet J Rare Dis. 2022;17(1):235.","journal-title":"Orphanet J Rare Dis"},{"key":"3288_CR8","doi-asserted-by":"crossref","unstructured":"Baas M, Huisman S, van Heukelingen J, Koekkoek G, Laan H, Hennekam RC. Building treasures for rare disorders. Eur J Med Genet 2015;58(1):11\u201313.","DOI":"10.1016\/j.ejmg.2014.10.006"},{"issue":"4","key":"3288_CR9","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajmg.c.31738","volume":"181","author":"A Foster","year":"2019","unstructured":"Foster A, Zachariou A, Loveday C, Ashraf T, Blair E, Clayton-Smith J, et al. The phenotype of Sotos syndrome in adulthood: a review of 44 individuals. Am J Med Genet. 2019;181(4):502\u20138.","journal-title":"Am J Med Genet"},{"key":"3288_CR10","doi-asserted-by":"crossref","unstructured":"Douzgou S, Dell\u2019Oro J, Fonseca CR, Rei A, Mullins J, Jusiewicz I, et al. The natural history of adults with Rubinstein-Taybi syndrome: a families-reported experience. Eur J Hum Genet 2022;30(7):841\u2013847.","DOI":"10.1038\/s41431-022-01097-8"},{"key":"3288_CR11","unstructured":"Rare Disease Registry. Sanford Research. Available at: https:\/\/research.sanfordhealth.org\/rare-disease-registry. Accessed May 20, 2023."},{"key":"3288_CR12","doi-asserted-by":"crossref","unstructured":"Yoneda Y, Saitsu H, Touyama M, Makita Y, Miyamoto A, Hamada K, et al. Missense mutations in the DNA-binding\/dimerization domain of NFIX cause Sotos-like features. J Hum Genet 2012;57(3):207\u2013211.","DOI":"10.1038\/jhg.2012.7"},{"key":"3288_CR13","doi-asserted-by":"publisher","first-page":"17022","DOI":"10.1038\/hgv.2017.22","volume":"4","author":"T Oshima","year":"2017","unstructured":"Oshima T, Hara H, Takeda N, Hasumi E, Kuroda Y, Taniguchi G, et al. A novel mutation of NFIX causes Sotos-like syndrome (Malan syndrome) complicated with thoracic aortic aneurysm and dissection. Human Genome Var. 2017;4:17022.","journal-title":"Human Genome Var"},{"key":"3288_CR14","doi-asserted-by":"crossref","unstructured":"Bellucco FT, de Mello CB, Meloni VA, Melaragno MI. Malan syndrome in a patient with 19p13.2p13.12 deletion encompassing NFIX and CACNA1A genes: case report and review of the literature. Mol Genet Genom Med 2019;7(12):e997.","DOI":"10.1002\/mgg3.997"},{"key":"3288_CR15","doi-asserted-by":"crossref","unstructured":"Hancarova M, Havlovicova M, Putzova M, Vseticka J, Prchalova D, Stranecky V, et al. Parental gonadal but not somatic mosaicism leading to de novo NFIX variants shared by two brothers with Malan syndrome. Am J Med Geneti A 2019;179(10):2119\u20132123.","DOI":"10.1002\/ajmg.a.61302"},{"key":"3288_CR16","doi-asserted-by":"crossref","unstructured":"Sihombing NRB, Winarni TI, van Bokhoven H, van der Burgt I, de Leeuw N, Faradz SMH. Pathogenic variant in NFIX gene affecting three sisters due to paternal mosaicism. Am J Med Genet A 2020;182(11):2731\u20132736.","DOI":"10.1002\/ajmg.a.61835"},{"issue":"1","key":"3288_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.gene.2012.08.040","volume":"511","author":"M Priolo","year":"2012","unstructured":"Priolo M, Grosso E, Mamm\u00ec C, Labate C, Naretto VG, Vacalebre C, Caridi P, Lagan\u00e0 C. A peculiar mutation in the DNA-binding\/dimerization domain of NFIX causes Sotos-like overgrowth syndrome: a new case. Gene. 2012;511(1):103\u20135.","journal-title":"Gene"},{"issue":"9","key":"3288_CR18","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.ejmg.2015.06.009","volume":"58","author":"F Gurrieri","year":"2015","unstructured":"Gurrieri F, Cavaliere ML, Wischmeijer A, Mamm\u00ec C, Neri G, Pisanti MA, et al. NFIX mutations affecting the DNA-binding domain cause a peculiar overgrowth syndrome (Malan syndrome): a new patients series. Eur J Med Genet. 2015;58(9):488\u201391.","journal-title":"Eur J Med Genet"},{"key":"3288_CR19","doi-asserted-by":"crossref","unstructured":"Van Groenendael S, Giacovazzi L, Davison F, Holtkemper O, Huang Z, Wang Q, et al. High quality, patient centred and coordinated care for Alstrom syndrome: a model of care for an ultra-rare disease. Orphanet J Rare Dis 2015;10:149.","DOI":"10.1186\/s13023-015-0366-y"},{"key":"3288_CR20","doi-asserted-by":"crossref","unstructured":"Alfieri P, Macchiaiolo M, Collotta M, Montanaro FAM, Caciolo C, Cumbo F, et al. Characterization of cognitive, language and adaptive profiles of children and adolescents with Malan syndrome. J Clin Med 2022;11(14).","DOI":"10.3390\/jcm11144078"},{"key":"3288_CR21","doi-asserted-by":"crossref","unstructured":"Alfieri P, Montanaro FAM, Macchiaiolo M, Collotta M, Caciolo C, Galassi P, et al. Behavioral profiling in children and adolescents with Malan syndrome. Front Child Adolescent Psychiatry 2023.","DOI":"10.3389\/frcha.2023.1106228"},{"key":"3288_CR22","doi-asserted-by":"crossref","unstructured":"Inoue K, Kato S, Numaga J, Sakurai M, Ohara C, Ouchi M, et al. Optic disk pallor and retinal atrophy in Sotos syndrome (cerebral gigantism). Am J Ophthalmol 2000;130(6):853\u2013854.","DOI":"10.1016\/S0002-9394(00)00711-X"},{"key":"3288_CR23","doi-asserted-by":"crossref","unstructured":"Nalini A, Biswas A. Sotos syndrome: an interesting disorder with gigantism. Ann Indian Acad Neurol 2008;11(3):190\u2013192.","DOI":"10.4103\/0972-2327.42941"},{"key":"3288_CR24","unstructured":"Tatton-Brown K, Cole TR, Rahman N. Sotos Syndrome. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, Gripp KW, et al, editors. GeneReviews\u00ae Seattle (WA): University of Washington, Seattle; 1993."},{"key":"3288_CR25","doi-asserted-by":"crossref","unstructured":"Cecchi AC, Haidar A, Marin I, Kwartler CS, Prakash SK, Milewicz DM. Aortic root dilatation and dilated cardiomyopathy in an adult with Tatton-Brown-Rahman syndrome. Am J Med Genet A 2022;188(2):628\u2013634.","DOI":"10.1002\/ajmg.a.62541"},{"issue":"12","key":"3288_CR26","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/jir.12787","volume":"64","author":"PA Mulder","year":"2020","unstructured":"Mulder PA, van Balkom IDC, Landlust AM, Priolo M, Menke LA, Acero IH, et al. Development, behaviour and sensory processing in Marshall-Smith syndrome and Malan syndrome: phenotype comparison in two related syndromes. J Intell Disabil Res JIDR. 2020;64(12):956\u201369.","journal-title":"J Intell Disabil Res JIDR"},{"key":"3288_CR27","doi-asserted-by":"crossref","unstructured":"Antolini G, Colizzi M. Where do neurodevelopmental disorders go? Casting the eye away from childhood towards adulthood. Healthcare 2023;11(7):1015.","DOI":"10.3390\/healthcare11071015"},{"issue":"11","key":"3288_CR28","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1111\/jan.13985","volume":"75","author":"M Brown","year":"2019","unstructured":"Brown M, Macarthur J, Higgins A, Chouliara Z. Transitions from child to adult health care for young people with intellectual disabilities: a systematic review. J Adv Nurs. 2019;75(11):2418\u201334.","journal-title":"J Adv Nurs"},{"issue":"10","key":"3288_CR29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1089\/cap.2021.0042","volume":"31","author":"KC Dominick","year":"2021","unstructured":"Dominick KC, Andrews HF, Kaufmann WE, Berry-Kravis E, Erickson CA. Psychotropic drug treatment patterns in persons with fragile X syndrome. J Child Adolesc Psychopharmacol. 2021;31(10):659\u201369.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"3288_CR30","doi-asserted-by":"crossref","unstructured":"Sinnema M, Maaskant MA, van Schrojenstein Lantman-de Valk, Henny M. J., Boer H, Curfs LMG, Schrander-Stumpel CTRM. The use of medical care and the prevalence of serious illness in an adult Prader\u2013Willi syndrome cohort. European J Med Genet 2013;56(8):397\u2013403.","DOI":"10.1016\/j.ejmg.2013.05.011"},{"key":"3288_CR31","doi-asserted-by":"crossref","unstructured":"Koch AD, Dobrindt J, Sch\u00fctzwohl M. Prevalence of psychotropic medication and factors associated with antipsychotic treatment in adults with intellectual disabilities: a cross\u2010sectional, epidemiological study in Germany. J Intellectual Disabil Res 2021;65(2):186\u2013198.","DOI":"10.1111\/jir.12802"},{"key":"3288_CR32","doi-asserted-by":"crossref","unstructured":"Bowring DL, Totsika V, Hastings RP, Toogood S, McMahon M. Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study. Journal of Intellectual Disability Research 2017;61(6):604\u2013617.","DOI":"10.1111\/jir.12359"},{"issue":"9","key":"3288_CR33","doi-asserted-by":"publisher","first-page":"817","DOI":"10.4088\/JCP.v63n0912","volume":"63","author":"MM Ohayon","year":"2002","unstructured":"Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry. 2002;63(9):817\u201325.","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"3288_CR34","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1016\/j.ridd.2013.08.030","volume":"34","author":"L Vereenooghe","year":"2013","unstructured":"Vereenooghe L, Langdon PE. Psychological therapies for people with intellectual disabilities: a systematic review and meta-analysis. Res Dev Disabil. 2013;34(11):4085\u2013102.","journal-title":"Res Dev Disabil"},{"issue":"1","key":"3288_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000271910","volume":"73","author":"GL Spadoni","year":"2010","unstructured":"Spadoni GL, Cianfarani S. Bone age assessment in the workup of children with endocrine disorders. Horm Res Paediatr. 2010;73(1):2\u20135.","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"3288_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s11689-017-9191-z","volume":"9","author":"J Wang","year":"2017","unstructured":"Wang J, Ethridge LE, Mosconi MW, White SP, Binder DK, Pedapati EV, et al. A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome. J Neurodev Disord. 2017;9(1):11.","journal-title":"J Neurodev Disord"},{"issue":"6","key":"3288_CR37","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s10803-019-03908-2","volume":"49","author":"AG Nicotera","year":"2019","unstructured":"Nicotera AG, Hagerman RJ, Catania MV, Buono S, Di Nuovo S, Liprino EM, et al. EEG abnormalities as a neurophysiological biomarker of severity in autism spectrum disorder: a pilot cohort study. J Autism Dev Disord. 2019;49(6):2337\u201347.","journal-title":"J Autism Dev Disord"},{"key":"3288_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.860662","volume":"15","author":"X Li","year":"2022","unstructured":"Li X, Li Z, Liang X, Liu D, Jiang M, Gao L, et al. CACNA1A mutations associated with epilepsies and their molecular sub-regional implications. Front Mol Neurosci. 2022;15: 860662.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"3288_CR39","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11940-012-0209-2","volume":"15","author":"P Garcia-Filion","year":"2013","unstructured":"Garcia-Filion P, Borchert M. Optic nerve hypoplasia syndrome: a review of the epidemiology and clinical associations. Curr Treat Options Neurol. 2013;15(1):78\u201389.","journal-title":"Curr Treat Options Neurol"},{"key":"3288_CR40","volume-title":"Optic Atrophy","author":"SS Ahmad","year":"2023","unstructured":"Ahmad SS, Kanukollu VM. Optic Atrophy. StatPearls Treasure Island: StatPearls Publishing; 2023."},{"key":"3288_CR41","unstructured":"Aazh H, Knipper M, Danesh AA, Cavanna AE, Andersson L, Paulin J, et al. Insights from the third international conference on hyperacusis: causes, evaluation, diagnosis, and treatment. Noise Health 2018;20(95):162\u2013170."},{"issue":"4","key":"3288_CR42","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3109\/13668250.2017.1310829","volume":"43","author":"J Robertson","year":"2018","unstructured":"Robertson J, Baines S, Emerson E, Hatton C. Prevalence of constipation in people with intellectual disability: a systematic review. J Intellect Dev Disabil. 2018;43(4):392\u2013406.","journal-title":"J Intellect Dev Disabil"},{"issue":"4","key":"3288_CR43","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.ridd.2012.03.003","volume":"33","author":"E van de Wouw","year":"2012","unstructured":"van de Wouw E, Evenhuis HM, Echteld MA. Prevalence, associated factors and treatment of sleep problems in adults with intellectual disability: a systematic review. Res Dev Disabil. 2012;33(4):1310\u201332.","journal-title":"Res Dev Disabil"},{"issue":"1","key":"3288_CR44","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00415-020-10153-6","volume":"268","author":"J Peters","year":"2021","unstructured":"Peters J, Vijiaratnam N, Angus-Leppan H. Tics induced by antiepileptic drugs: a pragmatic review. J Neurol. 2021;268(1):321\u201336.","journal-title":"J Neurol"},{"key":"3288_CR45","doi-asserted-by":"crossref","unstructured":"Butler MG, Victor AK, Reiter LT. Autonomic nervous system dysfunction in Prader\u2013Willi syndrome. Clin Autonom Res. 2022.","DOI":"10.1007\/s10286-022-00909-7"},{"key":"3288_CR46","doi-asserted-by":"crossref","unstructured":"Findlay L, Williams ACdC, Baum S, Scior K. Caregiver Experiences of Supporting Adults with Intellectual Disabilities in Pain. J Appl Res Intellect Disabil 2015;28(2):111\u2013120.","DOI":"10.1111\/jar.12109"},{"issue":"1","key":"3288_CR47","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/nau.24798","volume":"41","author":"A von Gontard","year":"2022","unstructured":"von Gontard A, Hussong J, Yang SS, Chase J, Franco I, Wright A. Neurodevelopmental disorders and incontinence in children and adolescents: Attention-deficit\/hyperactivity disorder, autism spectrum disorder, and intellectual disability\u2014A consensus document of the International Children\u2019s Continence Society. Neurourol Urodyn. 2022;41(1):102\u201314.","journal-title":"Neurourol Urodyn"},{"key":"3288_CR48","doi-asserted-by":"crossref","unstructured":"Langan SM, Mulick AR, Rutter CE, Silverwood R, Asher I, Garc\u00eda-Marcos L, et al. Trends in eczema prevalence in children and adolescents: A Global Asthma Network Phase I Study. Clinical and Experimental Allergy 2023.","DOI":"10.1111\/cea.14276"},{"key":"3288_CR49","doi-asserted-by":"crossref","unstructured":"Messina G, Biressi S, Monteverde S, Magli A, Cassano M, Perani L, et al. Nfix regulates fetal-specific transcription in developing skeletal muscle. Cell 2010;140(4):554\u2013566.","DOI":"10.1016\/j.cell.2010.01.027"},{"key":"3288_CR50","doi-asserted-by":"crossref","unstructured":"Rossi G, Antonini S, Bonfanti C, Monteverde S, Vezzali C, Tajbakhsh S, et al. Nfix regulates temporal progression of muscle regeneration through modulation of myostatin expression. Cell Rep 2016;14(9):2238\u20132249.","DOI":"10.1016\/j.celrep.2016.02.014"},{"key":"3288_CR51","doi-asserted-by":"crossref","unstructured":"Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol 2020;16(4):223\u2013237.","DOI":"10.1038\/s41581-019-0244-2"},{"key":"3288_CR52","doi-asserted-by":"crossref","unstructured":"Yamasaki T, Hemond C, Eisa M, Ganocy S, Fass R. The changing epidemiology of gastroesophageal reflux disease: are patients getting younger. J Neurogastroenterol Motil. 2018; 24(4):559\u2013569.","DOI":"10.5056\/jnm18140"},{"issue":"4","key":"3288_CR53","first-page":"619","volume":"26","author":"Y Ye","year":"2019","unstructured":"Ye Y, Manne S, Treem WR, Bennett D. Prevalence of inflammatory bowel disease in pediatric and adult populations: recent estimates from large national databases in the United States, 2007\u20132016. Inflamm Bowel Dis. 2019;26(4):619\u201325.","journal-title":"Inflamm Bowel Dis"},{"key":"3288_CR54","doi-asserted-by":"crossref","unstructured":"Nimmakayalu M, Horton VK, Darbro B, Patil SR, Alsayouf H, Keppler-Noreuil K, et al. Apparent germline mosaicism for a novel 19p13.13 deletion disrupting NFIX and CACNA1A. Am J Med Genet 2013;161(5):1105\u20131109.","DOI":"10.1002\/ajmg.a.35790"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03288-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03288-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03288-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T12:57:06Z","timestamp":1722257826000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03288-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3288"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03288-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"assertion":[{"value":"25 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A waiver for formal approval was obtained from the Institutional Review Board of Amsterdam University Medical Centers, the Netherlands (W23_133 # 23.162). This investigation was performed in accordance with the ethical principles of the Declaration of Helsinki. Informed consent was obtained by all participants and information was provided voluntarily. Participations received no compensation for their participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All respondents gave written consent for publication of clinical and genetic data. Written informed consent for publication of one patient\u2019s clinical images was obtained from the parent of the patient. A copy of the consent form is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"282"}}